[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?]. [electronic resource]
Producer: 20140818Description: 25-34 p. digitalISSN:- 1576-6578
- Amantadine -- administration & dosage
- Antiparkinson Agents -- administration & dosage
- Cardiovascular Diseases -- chemically induced
- Catechol O-Methyltransferase
- Catechol O-Methyltransferase Inhibitors
- Clinical Trials as Topic
- Dopamine Agonists -- administration & dosage
- Drug Interactions
- Drug Therapy, Combination
- Enzyme Inhibitors -- administration & dosage
- Food-Drug Interactions
- Humans
- Indans -- administration & dosage
- Indoles -- therapeutic use
- Levodopa -- administration & dosage
- Mental Disorders -- chemically induced
- Monoamine Oxidase Inhibitors -- administration & dosage
- Multicenter Studies as Topic
- Parkinson Disease -- drug therapy
- Serotonin Syndrome -- etiology
- Treatment Outcome
No physical items for this record
Publication Type: English Abstract; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.